David Lodge

University of Bristol, Bristol, England, United Kingdom 
"David Lodge"
Mean distance: 16.33 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kang H, Park P, Han M, et al. (2020) (2,6)- and (2,6)-hydroxynorketamine inhibit the induction of NMDA receptor-dependent LTP at hippocampal CA1 synapses in mice. Brain and Neuroscience Advances. 4: 2398212820957847
Wallach J, Colestock T, Agramunt J, et al. (2019) Pharmacological characterizations of the legal high fluorolintane and isomers. European Journal of Pharmacology. 172427
Lodge D, Watkins JC, Bortolotto ZA, et al. (2018) The 1980s: D-AP5, LTP and a Decade of NMDA Receptor Discoveries. Neurochemical Research
Ingram R, Kang H, Lightman S, et al. (2018) Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology
Collingridge GL, Lee Y, Bortolotto ZA, et al. (2016) Antidepressant Actions of Ketamine Versus Hydroxynorketamine. Biological Psychiatry
Collingridge GL, Lodge D, Mayer M, et al. (2016) Ionotropic glutamate receptors: still exciting after all these years. Neuropharmacology
Kang H, Park P, Bortolotto ZA, et al. (2016) Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties. Neuropharmacology
Wallach J, Kang H, Colestock T, et al. (2016) Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues. Plos One. 11: e0157021
Wood CM, Nicolas CS, Choi SL, et al. (2016) Prevalence and influence of cys407* Grm2 mutation in Hannover-derived Wistar rats: mGlu2 receptor loss links to alcohol intake, risk taking and emotional behaviour. Neuropharmacology
Lodge D, Mercier MS. (2015) Ketamine and phencyclidine: the good, the bad and the unexpected. British Journal of Pharmacology. 172: 4254-76
See more...